Selective Killing of Cancer Cells Based on Loss of Heterozygosity and Normal Variation in the Human Genome: A New Paradigm for Anticancer Drug Therapy - Basilion, James P.; Schievella, Andrea R.; Burns, Erica; Rioux, Patrice; Olson, Jeffrey C.; Monia, Brett P.; Lemonidis, Kristina M.; Stanton, Vincent P.; Housman, David E. (Molecular pharmacology, 1999)
Keywords: Antineoplastic Agents - pharmacology; Antineoplastic Agents - therapeutic use; Cell Survival - drug effects; DNA-Binding Proteins - antagonists & inhibitors; DNA-Binding Proteins - genetics; Drug Design; Feasibility Studies; Gene Targeting; Genetic Variation; Genome, Human; HeLa Cells; Humans; Loss of Heterozygosity; Neoplasms - drug therapy; Neoplasms - genetics; Oligoribonucleotides, Antisense - pharmacology; Oligoribonucleotides, Antisense - therapeutic use; Replication Protein A; Suppression, Genetic; Tumor Cells, Cultured; LOH; RPA70; 20N-mer; GAPDH; PCR